Diphenhydramine Injection Shortage
Last Updated: May 14, 2025
Status: Current
Products Affected - Description
-
- Diphenhydramine injection, Mylan Institutional (Viatris), 50 mg/mL, 10 mL vial, 10 count, NDC 67457-0124-10 - discontinued
Reason for the Shortage
-
- Armas has diphenhydramine injection available.
- Fresenius Kabi has diphenhydramine injection available.
- Hikma has diphenhydramine injection available.
- Sagent has diphenhydramine injection available.
- Viatris discontinued diphenhydramine injection in December 2024.
Available Products
-
- Diphenhydramine injection, Armas Pharmaceuticals, 50 mg/mL, 1 mL vial, 5 count, NDC 72485-0101-05
- Diphenhydramine injection, Armas Pharmaceuticals, 50 mg/mL, 1 mL vial, 25 count, NDC 72485-0101-25
- Diphenhydramine injection, Fresenius Kabi, 50 mg/mL, 1 mL Simplist syringe, 10 count, NDC 76045-0102-10
- Diphenhydramine injection, Fresenius Kabi, 50 mg/mL, 1 mL vial, 25 count, NDC 63323-0664-01
- Diphenhydramine injection, Hikma, 50 mg/mL, 1 mL vial, 25 count, NDC 00641-0376-25
- Diphenhydramine injection, Sagent, 50 mg/mL, 1 mL vial, 25 count, NDC 25021-0481-01
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated May 14, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 14, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.